Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2022

Net Loss Per Share

Schedule of reconciliation of net loss

	For the Three Months Ended
	March 31,
	2022		2021
Net loss	$	(8,189,798)	$	(7,623,140)
Net loss - Non-controlling interest		(69,211)		(90,962)
Net loss attributable to Heat Biologics, Inc.	$	(8,120,587)	$	(7,532,178)
Weighted-average common shares outstanding, basic and diluted		25,593,948		24,199,916
Net loss per share, basic and diluted	$	(0.32)	$	(0.31)

Schedule of potentially dilutive securities

	For the Three Months Ended
	March 31,
	2022	2021
Outstanding stock options	3,003,914	1,697,910
Restricted stock subject to forfeiture and restricted stock units	46,859	259,874
Outstanding common stock warrants	747,383	747,383